Terrell E. Jones, MD

Assistant Professor of Pathology, Magee-Womens Hospital Pathology

Dr. Jones is a member of the Division of Anatomic Pathology and the Divisions of Breast and Gynecologic Pathology and of Cytopathology.

Clinical Expertise

Dr. Jones's clinical expertise is in gynecologic and breast pathology and in cytopathology.

Education & Training
BS - Carnegie Mellon University, 2013
MD - University of Pittsburgh School of Medicine, 2017
Residency - University of Pittsburgh Medical Center, 2021
Breast and Gynecological Pathology Clinical Instructorship - University of Pittsburgh Medical Center, 2022
Cytopathology Fellowship - University of Pittsburgh Medical Center, 2023
Research Interests
  • Molecular underpinnings and biomarker testing in breast and gynecological neoplasia
  • Practice patterns in cervical Papanicolaou cytology and HPV testing
  • Cervical HPV genotype distribution 
Representative Publications

View Dr. Jones's publications on PubMed:

  • Jones TE, Matsko J, Elishaev E, Clark BZ, Carter G, Harinath L, Zhao C. Changes over time in Papanicolaou cytology test and HPV test in a large women’s academic center laboratory [published online ahead of print, 2023 April 7]. JASC. 2023; doi.org/10.1016/j.jasc.2023.03.008
  • Tang X*, Jones TE*, Jiang W, et al. Extended human papillomavirus genotype distribution in cervical intraepithelial neoplasia and cancer: Analysis of 40 352 cases from a large academic gynecologic center in China [published online ahead of print, 2022 Nov 11]. J Med Virol. 2022;e28302. doi:10.1002/jmv.28302 *Denotes co-first authorship
  • Jones TE and Austin RM. The significant remaining challenge of screening for cervical glandular neoplasia. J Am Soc Cytopathol. 2022;11(1):1-2. doi:10.1016/j.jasc.2021.10.002
  • Jones TE, La HS, Upadhyay-Baskota S, Bhargava R, Jones MW. The Potential Prognostic and Therapeutic Implications of Prolactin Receptor and Growth Hormone-releasing Hormone Receptor Expression in Uterine Leiomyosarcomas. Int J Gynecol Pathol. 2022;41(6):566-572.
  • Jones TE, Onisko A, and Yu J. Change of Practice Patterns Following An Educational Comment on Reports of Benign-Appearing Endometrial Cells in Pap Tests: An Institutional Experience. Am J of Clin Path. Published: 16 September 2021. https://doi.org/10.1093/ajcp/aqab134
  • Jones TE*, Pradhan D*, Dabbs D, Bhargava R, Onisko A, and Jones M. Immunohistochemical Markers With Potential Diagnostic, Prognostic, and Therapeutic Significance in Uterine Carcinosarcoma: A Clinicopathologic Study of 43 Cases.  Int J of Gyn Path. 40(1):84-93, January 2021.  *Denotes co-first authorship
  • Jones TE, Onisko A, Austin RM. Personalized Medicine and Cervical Screening: Development of Individualized Quantitative Risk Assessments for Cervical Adenocarcinoma and Adenocarcinoma in situ. Acta Cytol. 2020 Dec 1:1-7. doi: 10.1159/000511620. PMID: 33260179.
  • Jones TE, Zou J, Tseng GC, Roy S, Bhargava R. The Utility of Next-Generation Sequencing in Advanced Breast and Gynecologic Cancers. Am J Clin Pathol. 2021;156(3):455-460. doi:10.1093/ajcp/aqaa256
  • Jones TE, Bellin MD, Yadav D, Freeman ML, Schwarzenberg SJ, Slivka A, Chennat JS, Beilman GJ, Chinnakotla S, Pruett TL, Kirchner V, Humar A, Wijkstrom M, Zureikat AH, Nikiforova MN, Wald AI, Whitcomb DC, Singhi AD. The histopathology of SPINK1-associated chronic pancreatitis. Pancreatology. 2020 Oct 16:S1424-3903(20)30777-8. doi: 10.1016/j.pan.2020.10.030. PMID: 33097431.  
  • Freeman TJ*, Jones TE*, Scoccimarro A, Henson-Cordwell S, Wheeler SE. Clinical Laboratory Detection of a High-Level Hemoglobin Abnormality in a Patient with Suspected Recreational Drug Ingestion, J Appl Lab Med. 2020; 5 (2): 401–405.  *Denotes co-first authorship 
  • Jones TE, Wyse AJ, Gibson SA. Hematolymphoid neoplasms are common in bone marrow biopsies performed for non-specific, diffuse marrow signal alterations on MRI. Ann of Diag Pathol. 2019; 40: 7-12.
  • Cohen DA, Dabbs DJ, Cooper KL, Amin M, Jones TE, Jones MW, Chivukula M, Trucco GA, Bhargava R. Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma. Am J Clin Pathol. 2012;138(6):796-802. doi:10.1309/AJCP6DKRND5CKVDD